Estados Unidos - inglés - NLM (National Library of Medicine)

novel laboratories, inc. - sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium sulfate (unii: 1k573lc5tv) (sulfate ion - unii:7is9n8kpmg), magnesium sulfate anhydrous (unii: ml30mj2u7i) (magnesium cation - unii:t6v3lhy838) - sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults. - gastrointestinal obstruction - bowel perforation - gastric retention - ileus - toxic colitis or toxic megacolon - known allergies to components of the kit [see description (11)] teratogenic effects: pregnancy category c. animal reproduction studies have not been conducted with sodium sulfate, potassium sulfate and magnesium sulfate oral solution. it is also not known whether sodium sulfate, potassium sulfate and magnesium sulfate oral solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. sodium sulfate, potassium sulfate and magnesium sulfate oral solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when sodium sulfate, potassium sulfate and magnesium

Israel - inglés - Ministry of Health

a.l. medi-market ltd. - sodium chloride - solution for infusion - sodium chloride 9 mg/ml - sodium chloride - short- term intravascular volume substitution. hypotonic dehydration or isotonic dehydration. vehicle solution for supplementary medication.fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.

Malta - inglés - Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Malta - inglés - Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Malta - inglés - Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Estados Unidos - inglés - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

baxter healthcare limited - sodium chloride - solution for infusion - 0.45 percent weight/volume - electrolyte solutions; sodium chloride

Estados Unidos - inglés - NLM (National Library of Medicine)

mylan institutional llc - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37) - sodium chloride 9 g in 1000 ml

Estados Unidos - inglés - NLM (National Library of Medicine)

baxter healthcare corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - sodium chloride 900 mg in 100 ml - potassium chloride in sodium chloride injection, usp is indicated as a source of water and electrolytes. potassium chloride in sodium chloride injection, usp is contraindicated in patients with:

Estados Unidos - inglés - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - sodium chloride 4.5 g in 1000 ml - potassium chloride in sodium chloride injection, usp is indicated as a source of water and electrolytes. none known. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an a